Funding for healthcare in Croatia is principally through the compulsory health insurance system which has been operated by the Croatian Institute for health Insurance (HZZO). The HZZO collects contributions from the working population and the government makes payments on behalf of those exempt, such as the elderly, the unemployed and dependents.
Some major items within the structure of HZZO’s expenditures are listed
Clinical treatments - EUR 1.07 billion
Prescription drugs - EUR 450 million
Primary healthcare - EUR 404 million
Orthopedic devices - EUR 98 million
Emergency medical treatments - EUR 92 million
The EUR 3.4 billion budget of the Croatian Institute for Health Insurance
(HZZO, www.hzzo-net.hr) provides treatment for approximately 4.36 million
insured persons annually in 49 public health centres, 22 general hospitals, 12
clinics, 40 special hospitals and 363 polyclinics.
As Croatian healthcare is a two-tier system, these figures do not include the
full cost of services provided in private healthcare institutions and private
consumption of medicines, nor a portion of hospital budgets that is provided
by local authorities.
Private spending on pharmaceuticals and other medical products is not included in these figures.
The total drug expenditures in Croatia in 2012 were around EUR 572.3 million,
and are expected to decrease by 5.1 percent in 2013.
Approximately 25 percent of all drug expenditures are attributable to various
groups of cardiovascular drugs. The second highest ranked group is nervous
system drugs, followed by immune system/cancer treatment drugs and
In 2013, the Croatian market for medical equipment and supplies is estimated
at EUR 177.1 million, and is primarily government funded. Approximately one
fourth of this market is new medical equipment. It is expected that the market
will expand at a rate of 5.0% per annum, reaching EUR 225.5 million by 2018.
The National Healthcare Development Strategy 2012-2020 developed by the
Croatian Ministry of Health will expand health-related IT systems in the
country and restructure the hospital sector.
Around 93% of the medical device market is supplied by imports. Croatia has a small domestic production sector, supplying both the domestic market and other countries from the former Yugoslavia.